Celebrating Our Second Conference
We brought together leading aging researchers and biotech investors for two action-packed days of science and business.
SUPPORTING AGING RESEARCH
On July 11th, 2019, we hosted our second conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, at the Frederick P. Rose Auditorium, part of the Cooper Union campus in New York City. We are delighted to annouce that the event was totally sold out and we are looking at moving to a bigger venue next year given the huge success our second year has enjoyed. This year was a big step up in terms of scale for us as we moved from the single-day of last year to the two-day event we hosted this year and over thirty industry-leading speakers!
Keith Comito at Ending Age-Related Diseases 2019 — Opening Speech | LEAF.
Aubrey de Grey at Ending Age-Related Diseases 2019 — Keynote Day 1 | LEAF.
Ronald Kohanski at Ending Age-Related Diseases 2019 – Keynote Day 2 | LEAF.
Michael Greve at Ending Age-Related Diseases 2019 – Rejuvenation Now! | LEAF.
Michael West at Ending Age-Related Diseases 2019 – The Reversal of the Aging of Human Cells | LEAF.
Doug Ethell at Ending Age-Related Diseases 2019 – A New Way to Treat Alzheimer’s | LEAF.
Morgan Levine at Ending Age-Related Diseases 2019 – Developing Aging Biomarkers| LEAF.
Maria Blasco at Ending Age-Related Diseases 2019 – Telomere-based therapeutic stratergies | LEAF.
Reason at Ending Age-Related Diseases 2019 – The failure of clinical translation | LEAF.
Kelsey Moody at Ending Age-Related Diseases 2019 – Macular Degeneration | LEAF.
Greg Fahy at Ending Age-Related Diseases 2019 – Regenerating the Human Thymus | LEAF.
Michael Lustgarten at Ending Age-Related Diseases 2019 – Role of the Microbiome on Muscle Strength | LEAF.
Qingsong Zhu at Ending Age-Related Diseases 2019 – Deep Learning for Drug Discovery | LEAF.
Peter Fedichev at Ending Age-Related Diseases 2019 – Biomarkers of Aging | LEAF.
Andrei Gudkov at Ending Age-Related Diseases 2019 – | LEAF.
James Peyer at Ending Age-Related Diseases 2019 – Investment aspects of rejuvenation biotechnology | LEAF.
John Lewis at Ending Age-Related Diseases 2019 – Senolytics | LEAF.
Huda Suliman – Drug Screening and Icaria Life Sciences| LEAF.
Jared Fischer – Senescent Cancer Cells | LEAF.
Joe Betts-Lacroix – Startup Funding | LEAF.
Kevin Strange – MSI-1436 | LEAF.
Sree Kant – Rejuvenation Investment | LEAF.
João Pedro de Magalhães – Longevity | LEAF.
Vadim Gladyshev – Longevity Signatures| LEAF.
WHAT OUR GUESTS THOUGHT
We had an amazing range of guests who came to join us from not just the United States but from all over the world. We had people from the pharmaceutical industry, investors and biotech VCs, researchers, enthusiasts, and several of the Lifespan Heroes, our monthly patrons, also made the journey. Here is what some of our guests and speakers had to say about the event.
LEAF has become one of the world’s most important forces in spearheading the crusade to bring aging to an end. Their advocacy work continues to gain prominence, and with their series of New York conferences, they are now bringing the most cutting-edge scientific advances to a general audience. These fantastic events are an invaluable US counterpart to the ones that SENS Research Foundation runs in Berlin, and they are making a great contribution to the anti-aging crusade.
– Dr. Aubrey de Grey, SENS Research Foundation
I can’t think of a better way for a venue to accelerate breakthroughs in human longevity than to put leading scientists and investors in the same room. The scientists get to directly meet investors and learn about the present and future funding landscape, while the investors get to meet key scientists and keep on top of the state of the art in the field of longevity research.
– Dr. Oliver Medvedik, Kanbar Center for Biomedical Engineering
Because of the nature of my work I get to go to several international conferences every year. I attended the Ending Age-Related Disease conference in NY this year and it is now at the top of my list. A perfect sized event with exceptional speakers and flawlessly ran, ideal for learning the latest in the Longevity field, both on the scientific and investment side of things. Also, great for networking and connecting with fellow longevitists. Well done Lifespan team!
– Maria Entraigues, SENS Research Foundation
I’m grateful that there are a growing number of people that are interested in studying and conquering aging and age-related diseases!
– Professor Michael Lustgarten, Tufts University
The Life Extension Advocacy Foundation volunteers once again put on a great conference in Manhattan, attracting some of the most influential researchers, investors, and entrepreneurs involved in the new and growing field of human rejuvenation. The event was characterized by extremely interesting presentations, ideas, and new data from work in progress in labs and companies. These are exciting times, and Ending Age-Related Diseases is a conference series well worth adding to your conference schedule.
– Reason, Repair Biotechnologies
THANK YOU EVERYONE
Firstly we wish to thank our wonderful guest speakers and panelists for taking the time to come to our conference and share their insights with us. We would also like to thank our official sponsors for supporting the conference and for helping to make the event possible.